Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Agreed fabius, SeroquelXR's basically a write off and we're gonna be lucky to book $5M revenues on FocalinXR this fiscal year.

With the worst part being of course that FDA approvals on Pristiq and Lamictal even if they do arrive won't fare any better than SeroquelXR is progressing because MNK is failing so miserably at commercializing generics these days and is instead still trying to sell their generics division off even though there's no interested bidders.

Another shining example about how all potential positive news that IPCI does seem to put out eventually ends up turning into an unexpected negative...and I personally have no clue anymore what it's gonna take to break out of that now established pattern of the past 4 years and start regaining/restoring all the lost market confidence in this stock.

IPCI has enough in their stagnant pipeline right now to create a reversal and get the share price trending northward above +$1 a share again...but what we don't know is whether or not their assembled executive mgmt. roster has what it takes to actually get it done/accomplished!

If they can find a way then it's not over for all us remaining core shareholders...but time's definitely ticking and June's only a couple of months away...so if they're ever gonna start advancing their pipeline and finding a way to rebuild lost market confidence April and May are the 2 most important months in their 8 and a half year PubCo history to start proving/doing it!